Publishing research using ab3573? Please let us know so that we can cite the reference in this datasheet.

ab3573 has been referenced in 5 publications.

  • Zhang Y  et al. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition. Am J Physiol Regul Integr Comp Physiol 307:R693-703 (2014). WB ; Mouse . PubMed: 24990856
  • Rector RS  et al. Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol Gastrointest Liver Physiol 300:G874-83 (2011). WB ; Rat . PubMed: 21350190
  • Zhao X & Li LY PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats. Am J Nephrol 28:598-606 (2008). WB ; Rat . PubMed: 18277067
  • Theve EJ  et al. Sex hormone influence on hepatitis in young male A/JCr mice infected with Helicobacter hepaticus. Infect Immun 76:4071-8 (2008). PubMed: 18559427
  • McCarthy ET  et al. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier. Kidney Int 67:152-6 (2005). PubMed: 15610238

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"